B10 L-BPA
Alternative Names: B10-L-BPA; Boron Neutron Capture Therapy - Heron Neutron Medical CorpLatest Information Update: 04 Jul 2025
At a glance
- Originator Heron Neutron Medical Corp.
- Class Antineoplastics; Radiopharmaceuticals
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Meningioma
Most Recent Events
- 04 Jun 2025 Preclinical trials in Brain cancer in Taiwan (Parenteral)
- 04 Jun 2025 Heron Neutron Medical Corp plans a phase I/II trial for Brain cancer (NCT07003139)
- 14 Oct 2024 Phase-I/II clinical trials in Meningioma (Second-line therapy or greater) in Taiwan (Parenteral) (NCT06668987)